nephrocystin Activators
The chemical class denoted as Nephrocystin Activators represents a heterogeneous collection of compounds selected for their potential to influence the activity of nephrocystin, a protein encoded by the NPHP1 gene. While direct activators may not be precisely identified, these compounds operate through intricate interactions with the Wnt/β-catenin signaling pathway and related cellular processes, suggesting a nuanced regulatory role in nephrocystin function. Activators of this class act as a GSK-3β inhibitors. Its potential to activate nephrocystin stems from its ability to stabilize β-catenin, a key player in the Wnt/β-catenin pathway. By inhibiting GSK-3β, phosphorylation is distrupted and subsequent degradation of β-catenin, facilitating its accumulation and potential engagement in the activation of nephrocystin. This mechanism underscores the importance of the Wnt/β-catenin pathway in the regulation of nephrocystin and positions lithium as a chemical modulator capable of influencing nephrocystin activity indirectly.
Nephrocystin Activators further contribute to the chemical class by affecting the Wnt/β-catenin pathway. They inhibits β-catenin-mediated transcription, potentially interfering with downstream events that could activate nephrocystin. In addition, they also may indirectly activate nephrocystin by alleviating its inhibition, allowing for heightened Wnt signaling. Nephrocystin Activators play a crucial role by disrupting GSK-3β-mediated degradation of β-catenin. This inhibition leads to the accumulation of β-catenin, potentially participating in the activation of nephrocystin through modulation of the Wnt pathway. In essence, the nephrocystin activators exemplify a chemically diverse ensemble that intricately navigates the complexities of the Wnt/β-catenin signaling pathway, shedding light on potential avenues for the regulation of nephrocystin function within cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can potentially activate nephrocystin by modulating the Wnt/β-catenin signaling pathway. Lithium inhibits GSK-3β, a negative regulator of the Wnt pathway, leading to the stabilization and accumulation of β-catenin, which may influence nephrocystin activation. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
BIO is a GSK-3β inhibitor that can activate nephrocystin by inhibiting GSK-3β. This inhibition prevents GSK-3β from phosphorylating β-catenin, allowing β-catenin to accumulate and potentially influence nephrocystin activation through interactions with the Wnt signaling pathway. | ||||||
Norcantharidin | 29745-04-8 | sc-280719 | 5 g | $113.00 | 2 | |
Norcantharidin is known for its potential role in activating the Wnt/β-catenin pathway. By inhibiting protein phosphatase 2A (PP2A), norcantharidin prevents the dephosphorylation of β-catenin, leading to its stabilization and potential activation of nephrocystin through modulation of the Wnt signaling pathway. | ||||||
WAY 262611 | sc-397019 sc-397019A | 5 mg 25 mg | $131.00 $520.00 | 2 | ||
WAY-262611 is a potential activator of nephrocystin through the Wnt/β-catenin pathway. It functions as an inhibitor of sclerostin, which antagonizes Wnt signaling. Inhibition of sclerostin by WAY-262611 may lead to the activation of Wnt signaling and, subsequently, the potential activation of nephrocystin. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 is a tankyrase inhibitor that can activate nephrocystin by stabilizing axin, a negative regulator of the Wnt pathway. Inhibition of tankyrase prevents the degradation of axin, leading to increased destruction complex formation. This may result in the activation of the Wnt/β-catenin pathway, influencing nephrocystin activation. | ||||||
Thiazovivin | 1226056-71-8 | sc-361380 sc-361380A | 10 mg 25 mg | $284.00 $634.00 | 15 | |
IWP-2 is a Wnt pathway inhibitor that can activate nephrocystin by blocking Wnt secretion. Inhibition of Wnt secretion by IWP-2 may result in the stabilization of the destruction complex, preventing the degradation of β-catenin. This could potentially activate nephrocystin through modulation of the Wnt/β-catenin pathway. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC23766, an inhibitor of Rac1, may activate nephrocystin by inhibiting the Rac1 signaling pathway. Inhibition of Rac1 can potentially influence cellular processes related to nephrocystin activation, as Rac1 is involved in cytoskeletal remodeling and signaling cascades that may impact nephrocystin function. | ||||||